VRDN · Viridian Therapeutics, Inc.\DE · Executive Compensation

$22.43 +1.63 (+7.84%) At close · Oct 20

Russell 2000 member Rebalance outlook locked

Market Cap

$2.46B

113.29M

Volume · Oct 20 1.97M Avg daily vol (3M) 1.79M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Mahoney	Chief Executive Officer	$700,000	—	$1,058,098	$4,381,713	$630,000	$6,438	$6,776,249
Radhika Tripuraneni	—	$430,636	$50,000	—	$3,341,410	$253,529	$4,891	$4,080,466
Thomas Beetham	Chief Operating Officer	$545,001	—	$542,335	$2,245,871	$408,750	$19,225	$3,761,182
Seth Harmon	Chief Financial Officer	$480,000	—	$361,230	$1,495,898	$288,000	$17,651	$2,642,779
Jennifer Tousignant	Chief Legal Officer	$469,911	$50,000	$297,985	$1,233,979	$281,946	$18,094	$2,351,915

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jennifer Tousignant	Chief Legal Officer	$400,568	$150,000	—	$4,117,147	$234,000	$9,309	$4,911,024
Dr. Barrett Katz	Former Chief Medical Officer	$5,707	—	—	$1,064,201	—	$1,090,915	$2,160,823
Dr. Thomas Ciulla	Chief Medical Officer	$509,300	$144,000	—	$674,505	$264,836	$17,968	$1,610,609
Stephen Mahoney	Chief Executive Officer	$650,000	—	—	—	$464,750	$2,704	$1,117,454
Thomas Beetham	Chief Operating Officer	$500,000	—	—	—	$292,500	$17,000	$809,500
Seth Harmon	Senior Vice President, Finance and Accounting	$419,600	$123,000	—	—	$218,192	$9,867	$770,659

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott D. Myers	CEO	$549,475	—	$8,950,000	$26,786,134	—	$122,381	$36,407,990
Scott Myers	Former President, Chief Executive Officer and Director	$549,475	—	$8,950,000	$26,786,134	—	$122,381	$36,407,990
Stephen Mahoney	Chief Executive Officer	$112,847	$63,762	—	$12,302,728	—	$184	$12,479,521
Dr. Thomas Ciulla	Chief Medical Officer	$414,037	$235,088	—	$9,995,181	—	$1,806	$10,646,112
Seth Harmon	Senior Vice President, Finance and Accounting	$241,427	$372,200	—	$5,930,567	—	$4,332	$6,548,526
Thomas Beetham	Chief Operating Officer	$86,806	$40,130	—	$4,634,282	—	$184	$4,761,402
Dr. Barrett Katz	Former Chief Medical Officer	$502,228	—	—	$2,763,883	—	$9,888	$3,275,999
Jonathan Violin	Former President, Chief Executive Officer and Director	$59,209	—	—	$1,587,151	—	$564,712	$2,211,072
Jennifer Tousignant	Chief Legal Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Violin	Former President, Chief Executive Officer and Director	$601,200	$288,576	—	$3,754,644	—	$2,320	$4,646,740
Dr. Barrett Katz	Former Chief Medical Officer	$487,600	$136,528	—	$1,475,039	—	$11,488	$2,110,655
Barrett Katz	Chief Medical Officer	$487,600	$136,528	—	$1,475,039	—	$11,488	$2,110,655
Kristian Humer	Chief Financial and Business Officer	$561,800	$252,810	—	$1,206,850	—	$2,320	$2,023,780
Jennifer Tousignant	Chief Legal Officer	—	—	—	—	—	—	—
Stephen Mahoney	Chief Executive Officer	—	—	—	—	—	—	—
Dr. Thomas Ciulla	Chief Medical Officer	—	—	—	—	—	—	—
Thomas Beetham	Chief Operating Officer	—	—	—	—	—	—	—
Seth Harmon	Senior Vice President, Finance and Accounting	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan Violin	Former President, Chief Executive Officer and Director	$567,000	$408,240	—	$16,424,277	—	$9,021	$17,408,538
Barrett Katz	Chief Medical Officer	$440,833	$404,800	—	$7,308,118	—	$13,338	$8,167,089
Kristian Humer	Chief Financial and Business Officer	$230,871	$686,200	—	$6,790,787	—	$1,100	$7,708,958
Lee Rauch	Former President and Chief Executive Officer and Director	$22,542	$541,000	—	$307,926	—	$907,557	$1,779,054
Dr. Thomas Ciulla	Chief Medical Officer	—	—	—	—	—	—	—
Thomas Beetham	Chief Operating Officer	—	—	—	—	—	—	—
Jennifer Tousignant	Chief Legal Officer	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William S. Marshall	Former President and Chief Executive Officer	$424,832	—	—	$585,128	—	$1,176,859	$2,186,819
Lee Rauch	Former President and Chief Executive Officer and Director	$256,436	$270,500	—	$1,139,677	—	$3,798	$1,670,411
Diana Escolar	Former Chief Medical Officer	$417,473	$277,780	—	$164,492	—	$5,873	$865,618
Jason Leverone	Chief Financial Officer, Treasurer, and Secretary	$365,650	—	—	$112,715	—	$4,655	$483,020

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William S. Marshall	Former President and Chief Executive Officer	$521,000	—	—	$551,302	—	$3,640	$1,075,942
Paul D. Rubin	Former Executive Vice President, Research and Development	$426,000	—	—	$206,738	—	—	$632,738
Diana Escolar	Former Chief Medical Officer	$372,600	$111,780	—	$59,408	—	$6,217	$550,005
Jason Leverone	Chief Financial Officer, Treasurer, and Secretary	$355,000	—	—	$178,223	—	$4,584	$537,807

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William S. Marshall	President and Chief Executive Officer	$490,000	—	—	$1,350,005	$147,000	—	$1,987,005
Paul D. Rubin	Former Executive Vice President, Research and Development	$410,000	—	—	$468,369	$98,400	—	$976,769
Jason Leverone	Chief Financial Officer	$340,000	—	—	$413,267	$71,400	—	$824,667

Executive changes

Person	Role	Change	Effective	Filed
Sarah Gheuens, M.D., Ph.D.	Class I director	Appointed	2025-06-20	2025-06-24
Chris Cain, Ph.D.	Class I director	Appointed	2025-06-20	2025-06-24
Jeff Ajer	Class I director	Appointed	2025-06-20	2025-06-24
Jeff Ajer	Class I director	Appointed	2025-04-07	2025-04-07
Peter Harwin	member of the Board	Resigned	2025-03-10	2025-03-10
Christopher Cain, Ph.D.	chairperson of the Nominating and Corporate Governance Committee	Appointed	2025-03-10	2025-03-10
Christopher Cain, Ph.D.	Class I director	Appointed	2025-03-10	2025-03-10
Seth Harmon	Chief Financial Officer	Appointed	2025-01-01	2025-01-10
Thomas Ciulla	Chief Medical Officer	Appointed	2024-01-03	2024-01-08
Scott Myers	member of the board of directors	Resigned	2023-10-29	2023-11-02
Thomas Beetham	Chief Operating Officer	Appointed	2023-10-30	2023-10-30
Stephen Mahoney	Class III Director	Appointed	2023-10-30	2023-10-30
Stephen Mahoney	President and Chief Executive Officer	Appointed	2023-10-30	2023-10-30
Dr. Sarah Gheuens	Class I director	Appointed	2023-09-21	2023-09-25
Kristian Humer	Chief Financial Officer and Chief Business Officer	Resigned	2023-09-12	2023-09-12
Jennifer K. Moses	Class II director	Appointed	2023-06-14	2023-06-16
Tomas Kiselak	Class II director	Appointed	2023-06-14	2023-06-16
Carrie Melvin	Chief Operating Officer	Terminated	2023-04-11	2023-04-12
Jonathan Violin	member of the Board of Directors	Resigned	2023-02-06	2023-02-06
Jonathan Violin	President and Chief Executive Officer	Terminated	2023-02-06	2023-02-06
Scott Myers	Class III Director	Appointed	2023-02-06	2023-02-06
Scott Myers	President and Chief Executive Officer	Appointed	2023-02-06	2023-02-06

Leadership

Scott Myers CEO, Board Member
Stephen Mahoney CEO, Board Member
Tomas Kiselak Chairman
Seth Harmon CFO
Jonathan Violin COO
Lee Rauch COO, Board Member
Thomas Beetham COO
Lara Meisner General Counsel
Kristian Humer Chief Accounting Officer
Arlene M. Morris Board Member
Chris Cain Board Member
Chris Cain, Ph.D. Board Member
Christopher Cain, Ph.D. Board Member
Jeff Ajer Board Member
Jennifer K. Moses Board Member
Sarah Gheuens Board Member
Sarah Gheuens, M.D., Ph.D. Board Member

Key facts CIK 1590750 CUSIP 92790C104 13F (30d) 10 filings 10 filers Visit website Investor relations